Dahiroc, Rachel L.
HRN: 04-03-01 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2025
CEFTRIAXONE 1G (VIAL)
06/02/2025
06/09/2025
IV
2G
OD
UTI
Waiting Final Action
06/09/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/09/2025
06/16/2025
IV
250mg
Q24H
UTI
Waiting Final Action
06/09/2025
AZITHROMYCIN 500MG TABLET (TAB)
06/09/2025
06/13/2025
PO
500mg
OD
CAP
Waiting Final Action